STERIS plc 8-K Report: Key Financial Insights & Debt Instruments Overview

$STE
Form 8-K
Filed on: 2025-03-03
Source
STERIS plc 8-K Report: Key Financial Insights & Debt Instruments Overview

Based on the provided section of the financial report, here are the key pieces of information and insights extracted:

  1. Entity Identification:
  • Company: STERIS plc
  • CIK Number: 0001757898
  • SEC Filing Type: 8-K
  • Filing Date: March 3, 2025
  1. Stock Information:
  • Type of Shares: Ordinary Shares
  • Par Value: $0.001
  • Stock Exchange: NYSE (New York Stock Exchange)
  1. Debt Instruments:
  • 2.700% Senior Notes:
    • Due Date: 2031
    • Ticker Symbol: STE/31
  • 3.750% Senior Notes:
    • Due Date: 2051
    • Ticker Symbol: STE/51
  1. Context Information:
  • The report covers a specific duration from March 3, 2025, to March 3, 2025, suggesting this may be a reporting of a particular event or condition as of that date.
  1. Location:
  • Address: 70 Sir John Rogerson’s Quay, Dublin 2, D02 R296, Ireland.

Insights:

  • The company is actively involved in financial instruments, indicated by the presence of senior notes with specified maturity dates, which may indicate strategic funding or refinancing plans.
  • The low par value of ordinary shares suggests potential for a larger number of shares outstanding but does not provide immediate insights into the market valuation.
  • The filing type (8-K) indicates that this report may be disclosing significant corporate events or information that shareholders and potential investors should be aware of, possibly related to the debt instruments or other corporate developments.
  • The specific mention of stock and debt instruments suggests that STERIS plc might be in a period of focusing on its capital structure, either through raising funds or managing existing debt.

Overall, this section captures essential identifiers for the company, its financial instruments, and contextual information pertinent to stakeholders.